Ambea.St

Ambea AB maintains a highly leveraged capital structure, with long-term debt of SEK 12.64 billion against total equity of SEK 5.20 billion, resulting in a debt-to-equity ratio of 2.43. The company holds minimal cash reserves of SEK 133 million, leading to a negative net cash position and a current ratio of 0.41, which indicates significant short-term liquidity pressure. Despite these balance sheet constraints, the firm generates robust operating cash flow of SEK 2.17 billion and free cash flow of SEK 1.85 billion, suggesting that core operations are sufficient to service debt obligations. The market values the company at a price-to-earnings ratio of 17.38 and an EV/EBITDA of 17.45, reflecting a premium valuation relative to its asset base, with a price-to-book ratio of 2.22.

Profitability metrics show a gross profit of SEK 15.48 billion on revenue of SEK 16.04 billion, indicating a high gross margin of approximately 96.5%. Operating income stands at SEK 1.38 billion, yielding an operating margin of roughly 8.6%, while net income is SEK 665 million. Return on equity is 12.79%, and return on assets is 3.25%. Without cohort median data for direct comparison, these returns appear moderate for a healthcare services provider, particularly given the high leverage. The high gross margin suggests a business model with low direct cost of goods sold, typical of service-oriented or asset-light healthcare operations, but the net margin compression highlights significant operating expenses or interest costs.

Revenue concentration and geographic exposure cannot be assessed as segment and geographic data are absent from the input. The company reports total revenue of SEK 16.04 billion, but the breakdown by product line, service type, or region is not disclosed in the available financial snapshot. This lack of granularity limits the ability to evaluate diversification risks or specific growth drivers within the healthcare services portfolio.

Growth trajectory analysis is constrained by the absence of historical period data. The current financial snapshot provides a single-period view of revenue and net income, preventing the calculation of year-over-year growth rates or trend analysis. Consequently, the sustainability of the current revenue level and profitability cannot be evaluated against past performance. The company’s ability to maintain or grow its SEK 16.04 billion revenue base remains unverified by historical trends in the provided data.

Risk assessment highlights medium liquidity risk and low dilution risk. The key flag notes that net cash is negative after subtracting total debt, reinforcing the liquidity concerns identified in the capital structure analysis. The low dilution risk is supported by the fact that basic and diluted shares outstanding are identical at 80.1 million, indicating no significant options or convertible securities currently impacting share count. The primary risk lies in the company’s ability to manage its high debt load and short-term liabilities given the low current ratio.

Recent events include analyst coverage updates with a mean price target of 171.75 SEK and a median target of 168.50 SEK, implying potential upside from the current market price of 144.30 SEK. The mean recommendation is 1.50, with four analysts issuing strong buy or buy ratings and no hold ratings, suggesting strong institutional confidence. News observations indicate system-level reconciler activities for coverage closure, but no specific corporate actions, mergers, or regulatory events are disclosed in the recent news feed.